CCHMC IRB #2014-2318:V1
We want to learn if a drug, called omalizumab, will help children and adults with multiple food allergies be able to safely ingest the foods they are allergic to.
Omalizumab is investigational because the U.S. Food and Drug Administration (FDA) has not yet approved it for the treatment of food allergies in children and adults. It is approved for the treatment of asthma in children and adults,
12 and above.
Children, teens and adults, 4 to 55 years old, who have 2 or more food allergies, may be eligible to participate. Food allergies include: peanut, milk, egg, wheat, soy, sesame seed, fish, shellfish and/or certain tree nuts (almond, cashew, walnut, hazelnut, pecan).
Anyone with an oat allergy, moderate or severe persistent asthma, and/or eosinophilic disorders will not be able to participate.
Participants may receive from $20 to $40 per visit for their time and travel.
Lisa Thornbury Clark at 513-803-3663 or email@example.com.
Cincinnati Children's Multiple Food Allergies Study (ages 4-55) (PDF)